Author:
Kobayashi Tsuyoshi,Ishiyama Kohei,Ohdan Hideki
Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. The Japan Society of Hepatology. Clinical Practice Guidelines for Hepatocellular Carcinoma—The Japan Society of Hepatology 2009 update. Hepatol Res. 2010;40(Suppl 1):2–144.
2. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–2.
3. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359:1734–9.
4. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35:1164–71.
5. Wu CC, Ho YZ, Ho WL, Wu TC, Liu TJ. K. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg. 1995;82:122–6.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献